NURS FPX 4025 Assessment 3 explores the challenges and interventions for smoking cessation in patients with COPD, a progressive respiratory condition that significantly reduces quality of life. Smoking is the primary risk factor, and continued use accelerates disease progression. Structured smoking cessation programs that combine behavioral counseling, pharmacotherapy, and patient education have been shown to improve long-term abstinence, lung function, and overall patient outcomes. Using the PICO(T) framework, evidence-based literature was critically reviewed, focusing on credible sources from PubMed, CINAHL, Cochrane, and professional organizations such as the CDC and ALA. Nurses play a pivotal role in implementing these interventions, addressing barriers like nicotine dependence, emotional stress, and limited access to care, thereby enhancing patient outcomes and slowing COPD progression.
• Introduce the clinical issue or topic • Explain its relevance to nursing practice • State the purpose of the assessment
• Describe databases and search strategies used • Explain criteria for selecting credible sources • Discuss evaluation of source quality and relevance
• Summarize key findings from research sources • Compare and contrast different perspectives • Identify patterns and themes in the evidence
• Explain how research informs clinical decisions • Provide specific examples of practice applications • Discuss implications for patient outcomes
• Summarize key points and findings • Reinforce the importance of evidence-based practice • Suggest areas for future research or practice improvement
NURS FPX 4025 Assessment 3 Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung complaint that severely affects breathing and quality of life. Smoking is the primary trouble factor contributing to COPD, and continued smoking accelerates complaint progression. Despite the well-proved benefits of quitting smoking, multitudinous individualities struggle to quit due to nicotine dependence, cerebral stress, and limited access to support systems. COPD remains a significant public health concern in the United States, impacting roughly 16 million grown-ups (Centers for Disease Control and Prevention (CDC), 2024).
Quitting smoking not only slows complaint progression but also improves overall lung function and reduces the trouble of hospitalizations. Still, due to various walls, multitudinous COPD cases find it challenging to quit smoking successfully. This assessment evaluates the effectiveness of structured smoking cessation programs compared to standard comforting in abetting COPD cases in achieving long-term smoking abstinence and perfecting their lung health over six months.
COPD manifests through patient symptoms analogous to habitual coughing, breathlessness, and frequent respiratory infections. However, it can lead to severe complications, including hospitalizations, if left unmanaged. Smoking cessation remains the most effective intervention for breaking complaint progression, yet multitudinous cases face analogous challenges such as nicotine dependence, emotional stress, and lack of healthcare access (American Lung Association (ALA), 2024). Socioeconomic factors also play a vital part, as individuals from low-income backgrounds or those abiding in remote areas may struggle to pierce smoking conclusion resources.
Also, limited financial means may prevent some cases from accessing essential COPD specifics, such as inhalers or nicotine relief antidotes. Healthcare providers, particularly babysitters, are necessary in bridging these gaps by educating cases, furnishing support, and administering validation-predicated smoking conclusion strategies (Wang et al., 2024). By addressing these challenges, structured programs can enhance smoking cessation rates and ameliorate complaint operation.
A comprehensive literature review was conducted to gather validation on smoking cessation programs for COPD cases. Databases analogous to PubMed, CINAHL, Cochrane Library, and Google Scholar were searched using keywords including “COPD,” “smoking conclusion,” “nicotine relief remedy,” “behavioral comforting,” and “pharmacotherapy.” Boolean operators were used to upgrade the quest, placing a focus on studies specifically addressing smoking conclusions in COPD cases. The CRAAP criteria (Currency, Applicability, Authority, Accuracy, and Purpose) were applied to assess the credibility of sources. Peer-reviewed papers, regular reviews, and meta-analyses from estimable associations analogous to the CDC and ALA were prioritized.
Three pivotal studies illuminate the effectiveness of smoking cessation interventions. Wang et al. (2024) conducted a meta-analysis showing that quitting smoking significantly bettered lung function( FEV1 increase of 6.72), walking capability (6-MWT (FEV1 increased by 64.46), and oxygen situations (1.96 advanced). Han et al. (2023) set up that structured programs incorporating cognitive-behavioral remedy and pharmacotherapy resulted in advanced quit rates compared to standard comforting. Fu et al., crimes—these studies support the effectiveness of the structured smoking constitutions in the case’s problems to complete the problems.
The cessation of smoking is important for COPD cases, as it improves the general quality of pulmonary health and life. The structured smoking conclusion program, which includes practical comfort and pharmacotherapy, has shown a lower success rate than standard comfort. These programs give the necessary support, which helps cases to quit smoking and remove walls to reduce the complications related to COPD. Nurses and health professionals play an important part in the health care system and are responsible for enforcing these programs and guiding cases through the conclusion process. By espousing validation-predicated smoking conclusion interventions, healthcare systems can enhance patient issues and contribute to the long-term operation of COPD.
Alupo, P., Baluku, J., Bongomin, F., Siddharthan, T., Katagira, W., Ddungu, A., Hurst, J. R., Boven, van, Worodria, W., & Kirenga, B. J. (2024). Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countries. Expert Review of Respiratory Medicine. https://doi.org/10.1080/17476348.2024.2398639
American Lung Association (ALA). (2024). Learn about COPD | American Lung Association. Lung.org; American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/learn-about-copd
The Centers for Disease Control and Prevention (CDC) published information on COPD on June 12, 2024. COPD. Chronic Disease Indicators. https://www.cdc.gov/cdi/indicator-definitions/chronic-obstructive-pulmonary-disease.html
Fu, Y., Chapman, E. J., Boland, A. C., & Bennett, M. I. (2022). Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review. Palliative Medicine, 36(5), 770–782. https://doi.org/10.1177/02692163221079697
Gosak, L., Štiglic, G., Pruinelli, L., and Vrbnjak, D. published their work in 2024. PICOT questions and search strategy formulation: A novel approach using artificial intelligence automation. Journal of Nursing Scholarship. https://doi.org/10.1111/jnu.13036
Han, M. K., Fu, Y., Ji, Q., Duan, X., and Fang, X. (2023) conducted a study. The effectiveness of theory-based smoking cessation interventions in patients with chronic obstructive pulmonary disease: A meta-analysis. BMC Public Health, 23(1). https://doi.org/10.1186/s12889-023-16441-w
Hu, Y., Xie, J., Chang, X., Chen, J., Wang, W., Zhang, L., Zhong, R., Chen, O., Yu, X., & Zou, Y. (2021). Characteristics and predictors of abstinence among smokers of a smoking cessation clinic in Hunan, China. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.615817
Wang, Z., Qiu, Y., Ji, X., and Dong, L. published their study in 2024. Effects of smoking cessation on individuals with COPD: A systematic review and meta-analysis. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1433269
| Criteria | Excellent (A) | Satisfactory (B-C) | Needs Improvement (D-F) |
| Clinical Issue Identification | Clearly identifies COPD and smoking cessation challenges. | Issue identified but lacks depth or clarity. | Issue unclear or missing. |
| Evidence-Based Review | Thorough literature review with credible, relevant sources. | Some sources credible, reviews not comprehensive. | Limited or unreliable sources used. |
| Intervention Planning | Connects evidence to actionable, patient-centered smoking cessation interventions. | Interventions mentioned but not clearly linked to evidence. | Interventions unclear or unsupported. |
| Use of PICO(T) Framework | Correctly applies PICO(T) to structure clinical questions. | PICO(T) partially applied or incomplete. | PICO(T) not used or incorrectly applied. |
| Nursing Role & Application | Clearly defines the nursing role in implementing and supporting interventions. | Role described but not detailed or practical. | Role unclear or missing. |
| Organization & Clarity | Well-organized, concise, and logically structured. | Some organizational issues; mostly clear. | Disorganized or difficult to follow. |
| References & Credibility | High-quality, current, peer-reviewed sources properly cited. | Some references credible; minor errors. | Sources unreliable, outdated, or missing. |
The PICO(T) Framework is a tool used in substantiation-grounded exercises to help nurses and health professionals formulate a clear, responsible clinical question. Each letter represents a main element in the question: population, intervention, comparison, result, and time.
A well-structured PICO(T) question provides a roadmap for your exploration. This prevents you from being lost in a large ocean of literature by leading you to search for very specific information that’s directly applicable to your clinical problem, therefore ensuring that your substantiation is both focused and usable.
You can assess a composition’s credibility by looking at the journal it was published in (is it blink-reviewed?), the authors’ credentials and confederations (are they experts?), the date of publication (is it current?), and whether the study uses a sound methodology and cites authoritative sources.
You should look for findings that directly address the “outgrowth” (O) in your PICO (T) question. For this assessment, you’d look for quantitative data on smoking cessation rates, advancements in lung function (e.g., cessation FEV1 scores), or other health benefits that result from different interventions.
Instant access • No credit card
You cannot copy content of this page
Fill out the form below.